700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02144

Synthetic patientMETA-24 · Day 174 · 35–44 · F · baseline S15Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Improving
Nutritional resilience
Declining
Discontinuation risk
25%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S15
  2. Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 13.

Primary contributors, last 14 days
  • Toxicity-8
  • GI instability+5
  • Inflammatory activity-5
  • Nutritional resilience-5
  • Treatment adherence+3

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    30 min
    worsening · -4.7 vs previous 14 d
    Sleep duration
    Wearable
    5.7 h
    stable · -0.2 vs previous 14 d
    Energy level
    Daily log
    5/10
    worsening · -0.8 vs previous 14 d
    Steps
    Wearable
    4,178
    worsening · -318 vs previous 14 d
    GI burden
    Companion
    28/100
    worsening · +12.5 vs previous 14 d
    Adherence
    Companion
    84.3 %
    stable · +1.7 vs previous 14 d
    Sleep quality
    Wearable
    45.2/100
    worsening · -6.0 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    135 mg/dL
    worsening · +5.7 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 60 from the failing basin, 38 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +10.4
    • Butyrate producers intact
      hidden · steering +7.5
    • Protein
      supporter · GI -5.4 next day
    Main detractors to watch
    • Alcohol
      perturbation · steering -8.7
    • Poor-sleep week
      perturbation · steering -3
    • Dietary drift
      perturbation · steering -2.6
    • Alcohol
      detractor · GI +5.1 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -5.4supporter · 95%
    • Alcohol
      +5.1detractor · 95%
    • Dietary fat load
      +1.6no signal · 15%
    • Ultra-processed food
      +1.6no signal · 32%
    • Caffeine
      -1.2no signal · 21%
    • Insoluble fibre
      +1no signal · 19%
    • Simple carbohydrates
      -0.4no signal · 15%
    • Histamine load
      -0.2no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Autonomic recovery ↑45
      • WearableResting HR 75 bpm
      • WearableShort sleep window
    • Butyrate / short-chain fatty acid production ↓25
      • MicrobiomeF. prausnitzii depleted
    • Mucosal barrier integrity ↓10
      • WearableSleep 5.7 h, below personal baseline
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    • GLP1R rs6923761 A
      Altered receptor sensitivity
    Microbiome
    Shannon diversity 4.4 · butyrate capacity 59/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    67 ms
    Sleep
    6.1 h
    Steps
    3,671
    Resting HR
    75 bpm
    Daily log: GI score 28, nutritional resilience 63, adherence 84.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0252248%S01BR-03no change40
    P-0237545%S01——44
    P-0208739%S01BR-03no change40
    P-0204138%S01——27
    P-0243834%S01——32
    P-0221833%S01DT-01improved61
    P-0226932%S01——27
    P-0263832%S01BR-03improved41
    P-0242431%S01——62
    P-0227630%S01——57
    P-0256830%S01——51
    P-0268130%S01——51